Liposomal formulations of synthetic MUC1 peptides: effects of encapsulation versus surface display of peptides on immune responses - PubMed (original) (raw)
. 1998 Jul-Aug;9(4):451-8.
doi: 10.1021/bc970183n.
Affiliations
- PMID: 9667946
- DOI: 10.1021/bc970183n
Liposomal formulations of synthetic MUC1 peptides: effects of encapsulation versus surface display of peptides on immune responses
H H Guan et al. Bioconjug Chem. 1998 Jul-Aug.
Abstract
Synthetic human MUC1 peptides are important candidates for therapeutic cancer vaccines. To explore whether a human MUC1 peptide BP25 (STAPPAHGVTSAPDTRPAPGSTAPP) can be rendered immunogenic by incorporation in liposomes, the effects of physical association of the peptide with liposomes on immune responses were investigated. Lipid conjugated and nonconjugated MUC1 peptides were incorporated in liposomes with a composition of distearoylphosphatidylcholine/cholesterol/dimyristoylphosphatidylglyc erol (3:1:0.25, molar ratio) containing monophosphoryl lipid A (1% w/w of the total lipids). Liposomes were characterized for peptide retention by HPLC and for surface peptide display of MUC1 epitopes by flow cytometry. C57BL/6 mice were immunized with lipopeptide alone, peptide mixed with peptide-free liposomes, and peptide associated with liposomes in entrapped or surface-exposed forms. T cell proliferative responses, cytokine patterns, and antibody isotypes were studied. Results showed that immune responses were profoundly influenced by the liposome formulations. Physically associated, either encapsulated or surface-exposed, peptide liposomes elicited strong antigen-specific T cell responses, but not lipopeptide alone or peptide mixed with peptide-free liposomes. Analysis of the cytokines secreted by the proliferating T cells showed a high level of IFN-gamma and undetectable levels of IL-4, indicating a T helper type 1 response. Thus, physical association of the peptide with liposomes was required for T cell proliferative responses, but the mode of association was not critical. On the other hand, the nature of the association significantly affected humoral immune responses. Only the surface-exposed peptide liposomes induced MUC1-specific antibodies. A domination of anti-MUC1 IgG2b over IgG1 (94 versus 6%) was observed. Our results support the hypothesis that different immune pathways are stimulated by different liposome formulations. This study demonstrated that a liposome delivery system could be tailored to induce either a preferential cellular or humoral immune response.
Similar articles
- T cells recognize PD(N/T)R motif common in a variable number of tandem repeat and degenerate repeat sequences of MUC1.
Pisarev VM, Kinarsky L, Caffrey T, Hanisch FG, Sanderson S, Hollingsworth MA, Sherman S. Pisarev VM, et al. Int Immunopharmacol. 2005 Feb;5(2):315-30. doi: 10.1016/j.intimp.2004.10.004. Int Immunopharmacol. 2005. PMID: 15652762 - MUC1 mucin-mediated regulation of human T cells.
Agrawal B, Longenecker BM. Agrawal B, et al. Int Immunol. 2005 Apr;17(4):391-9. doi: 10.1093/intimm/dxh219. Epub 2005 Feb 14. Int Immunol. 2005. PMID: 15710907 - Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
Vandepapelière P, Horsmans Y, Moris P, Van Mechelen M, Janssens M, Koutsoukos M, Van Belle P, Clement F, Hanon E, Wettendorff M, Garçon N, Leroux-Roels G. Vandepapelière P, et al. Vaccine. 2008 Mar 4;26(10):1375-86. doi: 10.1016/j.vaccine.2007.12.038. Epub 2008 Jan 14. Vaccine. 2008. PMID: 18272264 Clinical Trial. - Liposomes as antigen delivery systems in viral immunity.
Reddy R, Nair S, Brynestad K, Rouse BT. Reddy R, et al. Semin Immunol. 1992 Apr;4(2):91-6. Semin Immunol. 1992. PMID: 1535521 Review. - Mechanisms of action of nonionic block copolymer adjuvants.
Hunter RL, McNicholl J, Lal AA. Hunter RL, et al. AIDS Res Hum Retroviruses. 1994;10 Suppl 2:S95-8. AIDS Res Hum Retroviruses. 1994. PMID: 7865341 Review.
Cited by
- Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens.
Watson DS, Endsley AN, Huang L. Watson DS, et al. Vaccine. 2012 Mar 16;30(13):2256-72. doi: 10.1016/j.vaccine.2012.01.070. Epub 2012 Feb 2. Vaccine. 2012. PMID: 22306376 Free PMC article. Review. - Nano/microparticle Formulations for Universal Influenza Vaccines.
Hendy DA, Amouzougan EA, Young IC, Bachelder EM, Ainslie KM. Hendy DA, et al. AAPS J. 2022 Jan 7;24(1):24. doi: 10.1208/s12248-021-00676-9. AAPS J. 2022. PMID: 34997352 Free PMC article. Review. - Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications.
Spicer CD , Jumeaux C , Gupta B , Stevens MM . Spicer CD , et al. Chem Soc Rev. 2018 May 21;47(10):3574-3620. doi: 10.1039/c7cs00877e. Chem Soc Rev. 2018. PMID: 29479622 Free PMC article. Review. - Key roles of adjuvants in modern vaccines.
Reed SG, Orr MT, Fox CB. Reed SG, et al. Nat Med. 2013 Dec;19(12):1597-608. doi: 10.1038/nm.3409. Epub 2013 Dec 5. Nat Med. 2013. PMID: 24309663 Review. - Co-delivery of a CD4 T cell helper epitope via covalent liposome attachment with a surface-arrayed B cell target antigen fosters higher affinity antibody responses.
Elbahnasawy MA, Donius LR, Reinherz EL, Kim M. Elbahnasawy MA, et al. Vaccine. 2018 Oct 1;36(41):6191-6201. doi: 10.1016/j.vaccine.2018.08.014. Epub 2018 Sep 7. Vaccine. 2018. PMID: 30197285 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous